XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.265
+0.005 (0.40%)
Nov 21, 2024, 3:10 PM EST - Market closed
XORTX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 4 | 12 | 26 | 9 | 8 | |
| Market Cap Growth | -55.45% | -63.14% | -53.60% | 177.78% | 19.02% | 29.48% | |
| Enterprise Value | 2 | -1 | 3 | 22 | 9 | 8 | |
| Last Close Price | 1.26 | 2.31 | 7.27 | 18.45 | 12.26 | 13.81 | |
| PB Ratio | 2.17 | 0.95 | 1.70 | 1.94 | 7.35 | -36.66 | |
| P/TBV Ratio | 2.37 | 0.98 | 1.75 | 1.97 | 9.04 | - | |
| Debt / Equity Ratio | 0.03 | 0.00 | 0.01 | - | - | -0.24 | |
| Quick Ratio | 7.09 | 11.90 | 6.96 | 26.97 | 0.18 | 0.05 | |
| Current Ratio | 7.39 | 13.80 | 7.21 | 28.78 | 1.99 | 0.63 | |
| Return on Equity (ROE) | -17.92% | -37.08% | -76.43% | -22.25% | -245.97% | -1146.60% | |
| Return on Assets (ROA) | -33.81% | -34.72% | -38.82% | -15.04% | -40.80% | -25.96% | |
| Return on Capital (ROIC) | -42.68% | -52.83% | -56.97% | -20.34% | -125.84% | -299.61% | |
| Earnings Yield | -17.02% | -49.17% | -64.82% | -6.15% | -13.91% | -8.11% | |
| FCF Yield | -94.52% | -150.08% | -75.44% | -18.71% | -7.88% | -3.22% | |
| Buyback Yield / Dilution | -36.19% | -33.91% | -35.25% | -47.77% | -24.34% | -1.79% | |
| Total Shareholder Return | -36.19% | -33.91% | -35.25% | -47.77% | -24.34% | -1.79% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.